REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
|Articles|July 29, 2022
Daily OTC Pearl: L-Lysine
Author(s)Saro Arakelians, PharmD
L-Lysine is a protein source that supports collagen synthesis.
Advertisement
OTC/Lifestyle Pearl of the Day: L-Lysine
Indication: L-Lysine is a protein source that supports collagen synthesis.
Insight:
- L-Lysine (from L-Lysine monohydrochloride) 1.0 g (1000 mg).
- Other Ingredients: Cellulose, croscarmellose sodium, silica, magnesium stearate (vegetable source), stearic acid (vegetable source) and vegetable coating. Contains no sugar, salt, starch, yeast, wheat, gluten, corn, soy, milk, egg, shellfish, or preservatives.
- Store in a cool, dry place.
- Directions: As a dietary supplement, take 1 tablet on an empty stomach 1 to 2 times daily, as needed.
Source:
Advertisement
Related to this article
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
The once-nightly drop, previously approved to reverse pupil dilation, met its primary end point in 2 phase 3 trials, with conjunctival hyperemia most common.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
Advertisement
Advertisement